Investigational Drug Information for Ifetroban
✉ Email this page to a colleague
What is the drug development status for Ifetroban?
Ifetroban is an investigational drug.
There have been 10 clinical trials for Ifetroban.
The most recent clinical trial was a Phase 2 trial, which was initiated on October 1st 2011.
The most common disease conditions in clinical trials are Respiratory Tract Diseases, Respiration Disorders, and Hypertension. The leading clinical trial sponsors are Cumberland Pharmaceuticals, Vanderbilt-Ingram Cancer Center, and American Heart Association.
Summary for Ifetroban
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 2,364 |
| WIPO Patent Applications | 848 |
| Japanese Patent Applications | 364 |
| Clinical Trial Progress | Phase 2 (2011-10-01) |
| Vendors | 16 |
Recent Clinical Trials for Ifetroban
| Title | Sponsor | Phase |
|---|---|---|
| Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF) or Non-IPF Progressive Pulmonary Fibrosis | Cumberland Pharmaceuticals | Phase 2 |
| Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy | Vanderbilt University Medical Center | Phase 2 |
| Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy | Cumberland Pharmaceuticals | Phase 2 |
Clinical Trial Summary for Ifetroban
Top disease conditions for Ifetroban
Top clinical trial sponsors for Ifetroban
US Patents for Ifetroban
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
